Close

Gambro BCT, Inc., medical device manfacturer soon to become CaridianBCT, Inc.,

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

Thermo Fisher Receives FDA Approval for...

The world leader when it comes to serving science,...

Virtual MRI Imaging with AI Aids...

During the magnetic resonance imaging (MRI) procedures, contrast agents...
Gambro BCT, Inc., the largest medical device manufacturer headquartered in Colorado, with worldwide revenues approaching $500M and 2300 employees, announced it will change its legal name to CaridianBCT, Inc. on July 14, 2008. The Lakewood, CO-based company was a subsidiary of Gambro AB, a previously publicly traded, multinational healthcare company based in Sweden. It currently operates as an independent U.S. corporation under a private ownership structure.

Gambro BCT, Inc., the largest medical device manufacturer headquartered in Colorado, with worldwide revenues approaching $500M and 2300 employees, announced it will change its legal name to CaridianBCT, Inc. on July 14, 2008.

The Lakewood, CO-based company was a subsidiary of Gambro AB, a previously publicly traded, multinational healthcare company based in Sweden. It currently operates as an independent U.S. corporation under a private ownership structure.

David B. Perez, President and Chief Executive Officer said,  CaridianBCT is built on a 44-year tradition of partnering with customers to provide superior products, services and technology. Our vision, ‘for better blood and better lives’ is accomplished by being a leading global provider of products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies.

The company is a leader in the blood bank technology industry, investing in research and development focused on enhancing blood quality, safety, supply and efficiency. Our Trima Accel®, COBE® Spectra and Spectra Optia® as well as our European Mirasol® and Atreus® systems are widely recognized as delivering the highest value and quality to customers around the world, said Perez. Under new name, CaridianBCT will continue to be a pioneer in blood banking and transfusion medicine, developing and commercializing innovation that meets the needs of our customers and the patients they serve.

Latest stories

Related stories

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Virtual MRI Imaging with AI Aids Better Tumor Detection

During the magnetic resonance imaging (MRI) procedures, contrast agents...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back